These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4568964

  • 1. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.
    Bartlett GL, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964
    [No Abstract] [Full Text] [Related]

  • 2. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE, Meyer TJ, Azuma I, Zbar B.
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.
    Bartlett GL, Zbar B.
    J Natl Cancer Inst; 1972 Jun; 48(6):1709-26. PubMed ID: 4341405
    [No Abstract] [Full Text] [Related]

  • 6. Systemic antitumor activity of Bacillus Calmette Guerin and purified protein derivatives against tumors in mice having tuberculin allergy.
    Abe S, Saito M, Yamazaki M, Mizuno D, Tsumita T.
    Jpn J Exp Med; 1978 Oct; 48(5):455-7. PubMed ID: 372638
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B, Taylor S, Levine M, Saffer E, Fisher ER.
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.
    Zbar B, Bernstein ID, Rapp HJ.
    J Natl Cancer Inst; 1971 Apr; 46(4):831-9. PubMed ID: 4324814
    [No Abstract] [Full Text] [Related]

  • 9. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P, Mathews HL.
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [Abstract] [Full Text] [Related]

  • 10. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB, Serrou B.
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [Abstract] [Full Text] [Related]

  • 11. Immunoprophylaxis of methylcholanthrene-induced tumors in mice with Bacillus Calmette-Guérin and methanol-extracted residue.
    Lavrin DH, Rosenberg SA, Connor RJ, Terry WD.
    Cancer Res; 1973 Mar; 33(3):472-7. PubMed ID: 4570271
    [No Abstract] [Full Text] [Related]

  • 12. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E, Mackaness GB.
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract] [Full Text] [Related]

  • 13. [BCG and experimental leukemia].
    Amiel JL, Berardet M.
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract] [Full Text] [Related]

  • 14. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO.
    Johns Hopkins Med J Suppl; 1974 Apr; 3():51-60. PubMed ID: 4370816
    [No Abstract] [Full Text] [Related]

  • 15. Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response.
    Hawrylko E, Mackaness GB.
    J Natl Cancer Inst; 1973 Nov; 51(5):1683-8. PubMed ID: 4587143
    [No Abstract] [Full Text] [Related]

  • 16. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G, Halle-Pannenko O, Bourut C, Hiu IJ.
    Johns Hopkins Med J Suppl; 1974 Nov; 3():85-102. PubMed ID: 4154074
    [No Abstract] [Full Text] [Related]

  • 17. Enhancement of lymphoma cell immunogenicity by infection with nononcogenic virus.
    Eaton MD, Heller JA, Scala AR.
    Cancer Res; 1973 Dec; 33(12):3293-8. PubMed ID: 4357358
    [No Abstract] [Full Text] [Related]

  • 18. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM, Riggs CW, Hanna MG.
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract] [Full Text] [Related]

  • 19. Systemic transfer of tumor immunity: delayed hypersensitivity and suppression of tumor growth.
    Wepsic HT, Zbar B, Rapp HJ, Borsos T.
    J Natl Cancer Inst; 1970 Apr; 44(4):955-63. PubMed ID: 11515063
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.